Spotlight
Commentary
Cultural Corner
Psychiatric Practice
Series
News
Job Board
CME/CE
Partners
Editorial
Subscribe
Tiffany N. Andry, MD
Articles
Emerging Treatments and Pharmacogenetics for Cocaine Use Disorder
Tiffany N. Andry, MD;Daryl Shorter, MD;Thomas R. Kosten, MD;American Academy of Addiction Psychiatry
May 31st 2016There are no FDA-approved pharmacotherapies for cocaine use disorder. Here: a review of the off-label use of promising medications for this addiction.
Latest Updated Articles
Published: July 13th 2025 | Updated: July 18th 2025
Clinician Tips in Prescribing New Xanomeline-Trospium for Schizophrenia
Published: March 19th 2021 | Updated: July 18th 2025
Mini Quiz: Treatment for Pedophilia?
Published: January 23rd 2017 | Updated: July 18th 2025
Mini Quiz: Characterizing Sexual Deviation
Published: July 14th 2025 | Updated: July 18th 2025
Eyes, Ears, and Emotion: Techniques to Tackle Diagnosing Bipolar Disorder
Published: July 12th 2025 | Updated: July 18th 2025
Toward a Muscarinic Agent Solution for the Presynaptic Dopamine Problem in Schizophrenia
Published: July 13th 2025 | Updated: July 18th 2025
Robust Efficacy and Decreased Side Effects with New Muscarinic Agent for Treating Schizophrenia
